JAVIER FLEITES: Open Payments
NPI 1699420059 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 37 payments from 14 companies in 2025. Trend: 2023 $933 · 2024 $465 · 2025 $806
Food & beverage: $771Education: $35
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 7 | $171 |
| Janssen Biotech, Inc. | 8 | $100 |
| Sumitomo Pharma America, Inc. | 6 | $99 |
| Janssen Scientific Affairs, LLC | 1 | $94 |
| ABBVIE INC. | 3 | $58 |
| Boston Scientific Corporation | 2 | $49 |
| TOLMAR, INC. | 2 | $43 |
| Teleflex LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| UROGEN PHARMA, INC. | 1 | $27 |
Products named: ERLEADA, ADSTILADRIN, BOTOX, GEMTESA, ORGOVYX, ELIGARD, BARRIGEL, IMFINZI.
Industry payments across FL — which companies pay providers there.
